YCBD Stock Analysis: Buy, Sell, or Hold?
YCBD - cbdMD, Inc. Common Stock
$0.49
-0.02 (-4.11%)
▼
5d:
+2.74%
30d:
-9.29%
90d:
-35.87%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When YCBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: YCBD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: YCBD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: YCBD is currently trading at $0.49, which is considered oversold relative to its 30-day fair value range of $0.50 to $0.58.
Technical Outlook: Technically, YCBD is in a strong downtrend. Immediate support is located at $0.47, while resistance sits at $0.62. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+309.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YCBD is in a strong downtrend. Immediate support is located at $0.47, while resistance sits at $0.62. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+309.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.50 -
$0.58
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 309.8% below Wall St target ($2.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.50 -
$0.58
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.47
Resistance Level
$0.62
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.32
Wall Street Target
$2.00
(+309.8%)
Revenue Growth (YoY)
20.6%
Profit Margin
-13.8%
Share & Embed Analysis
Last updated: August 24, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YCBD showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 50 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 49 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 50 HOLD |
